How many email patterns does STALICLA use?

STALICLA uses 2 known email patterns.

What domain does STALICLA use for work emails?

STALICLA uses stalicla.com for work email addresses.

Most Common Email Formats at STALICLA

STALICLA's most common email format is First.Last@stalicla.com (ex. John.Doe@stalicla.com), used for 97% of stalicla.com addresses. STALICLA uses 2 email patterns.

@stalicla.com

2 patterns

Format	Example	Share of stalicla.com
First.Last@stalicla.comMost common	John.Doe@stalicla.com	97%
LF@stalicla.com	DJ@stalicla.com	3%

Frequently Asked Questions

What does STALICLA do?

STALICLA was founded in 2017 and operates in the Biotechnology Research industry, alongside similar companies like Neuren Pharmaceuticals and Ovid Therapeutics. You can visit stalicla.com. Explore STALICLA's company overview page for more information.

What is STALICLA's email address format?

STALICLA's email format typically follows the pattern of First.Last@stalicla.com; this email format is used 97% of the time. Other contacts within LeadIQ's database had email formats such as LF@stalicla.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does STALICLA have currently?

STALICLA has approximately 23 employees as of October 2026. Key team members to contact include Ceo And Founder: L. D., Cto, Head Of Discovery And Data Science: E. G. and Head Of Clinical Operations: E. P. For more team information and contact data, explore STALICLA's employee directory with LeadIQ.

STALICLA Email Format

Q: What is STALICLA's email address format?

STALICLA's email format typically follows the pattern of ${fn}.${ln}. Other email formats include ${li}${fi}.

Biotechnology ResearchGeneva, Switzerland11-50 Employees

STALICLA is a Swiss clinical-stage biotechnology company focusing on Neuro Precision Medicine for neurodevelopmental and neuropsychiatric disorders. It aims to tailor therapies to specific patient subgroups, such as those with autism spectrum disorder, using an integrated, multi-omics approach to identify candidate drugs, with STP1 advancing toward Phase 2 trials. In the realm of Substance Use Disorder, the company collaborates with the National Institute on Drug Abuse (NIDA) to move STP7, for cocaine use disorder, into Phase 3 trials. Based in Geneva, Switzerland, STALICLA operates in the biotechnology research sector, pursuing precision medicines for brain disorders.

As a small to mid-sized biotech company, it sits within the Swiss life sciences landscape focusing on neurodevelopmental and neuropsychiatric indications with a pipeline spanning Phase 2 and Phase 3 trials. Recent leadership developments include the appointment of Dr. Purnanand Sarma as Chair of the Board in July 2024.

Most Common Email Formats at STALICLA

@stalicla.com

Need a specific person's email?

Frequently Asked Questions

What does STALICLA do?

What is STALICLA's email address format?

How many employees does STALICLA have currently?

STALICLA Email Format

Ready to create more pipeline?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Most Common Email Formats at STALICLA

@stalicla.com

Need a specific person's email?

Frequently Asked Questions

What does STALICLA do?

What is STALICLA's email address format?

How many employees does STALICLA have currently?

STALICLA Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.